František Folber

5PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2026
Survival Improvement of DLBCL Patients Treated with Third Line and Beyond in the Recent Era in the Czech Republic.

|Jul 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.

Simona Iacobelli, Stefan Schönland, Linda Koster

|Nov 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.

Matjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras

|Jul 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Gloria Tridello

|Aug 23, 2023
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience.

Tomáš Kabut, Barbora Weinbergerová, František Folber

Pageof 1

Frequent Collaborators

2 joint publications

Didier Blaise

2 joint publications

Patrick J Hayden

2 joint publications

Stefan Schönland

2 joint publications

Donal P McLornan